Intralipid Emulsion
Product Images NDC 0338-0520

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Intralipid (NDC 0338-0520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag 30 Pbp (Bag 30pbp)

This is a description of a Pharmacy Bulk Package of Intralipid®, a 30% intravenous fat emulsion. The package contains 500 mL of the emulsion and is not meant for direct infusion. The NDC number is 0358-0520-13.*

FDA Label Image

Image 2 (Inforuse30 Image2)

FDA Label Image

Image 3 (Inforuse30 Image3)

This text provides instructions for using a compounding set with a specific diameter of 5.6 +/- 0.1 mm. The instruction indicates to break off the tamper-evident arrow flag from the blue infusion port. However, the context in which these instructions apply is not clear.*

FDA Label Image

Image 4 (Inforuse30 Image4)

This text provides instructions for using an infusion port. It advises the user to hold the base of the port firmly and insert the spike straight through the center of the septum, making sure not to insert the spike at an angle. The user should also inspect the bag and contents for any particulate matter in a well-lit environment before use, discarding the bag if there are signs of discoloration or particulates.*

FDA Label Image

Image 5 (Inforuse30p Image5)

This text seems to be an instruction regarding transferring something from a bag to a compounding bag. It suggests to hang the bag on a hanger and commence with the transfer process. The context or content of this bag transfer is not available.*

FDA Label Image

Figure 1 (Instruct Fig1)

The Integrity indicator (Oxalert™) A should be inspected before removing the overwrap. If the indicator is black, the overwrap is damaged and the product should be discarded.*

FDA Label Image

Fatacid (Intralipid Figure 1 Fatacid Intralp)

FDA Label Image

Phsph (Intralipid Figure 10 Phph Intrlp)

FDA Label Image

R1 (Intralipid Figure 11 2nd R1c Intrlp)

FDA Label Image

R2 (Intralipid Figure 12 2 R2c)

FDA Label Image

Phoscl (Intralipid Figure 13 Phosclne Intrlp)

FDA Label Image

Phosam (Intralipid Figure 14 Phosamn Intrlp)

FDA Label Image

Hysyp (Intralipid Figure 15 Hygsyp Intrlp)

Not available. The text provided is not enough to generate a useful description. It seems to be a chemical formula, but it is incomplete and lacks context.*

FDA Label Image

R1c (Intralipid Figure 2 R1c Intralip)

FDA Label Image

R2c (Intralipid Figure 3 R2c Intralip)

FDA Label Image

R3c (Intralipid Figure 4 R3c Intralp)

FDA Label Image

Linacd (Intralipid Figure 5 Linacid Intralp)

FDA Label Image

Olacd (Intralipid Figure 6 Oleic Intrlp)

FDA Label Image

Palacd (Intralipid Figure 7 Palacd Intralp)

FDA Label Image

Lncacid (Intralipid Figure 8 2nd Linacd Intrlp)

FDA Label Image

Stracd (Intralipid Figure 9 Stear Intrlp)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.